U.S. Tuberculosis Diagnostics Market Size & Outlook
U.S. tuberculosis diagnostics market, 2018-2030 (US$M)
Related Markets
U.S. tuberculosis diagnostics market highlights
- The U.S. tuberculosis diagnostics market generated a revenue of USD 561.7 million in 2023 and is expected to reach USD 819.3 million by 2030.
- The U.S. market is expected to grow at a CAGR of 5.5% from 2024 to 2030.
- In terms of segment, detection of latent infection (skin test & igra) was the largest revenue generating test type in 2023.
- Detection of Drug Resistance (DST) is the most lucrative test type segment registering the fastest growth during the forecast period.
Tuberculosis diagnostics market data book summary
| Market revenue in 2023 | USD 561.7 million |
| Market revenue in 2030 | USD 819.3 million |
| Growth rate | 5.5% (CAGR from 2023 to 2030) |
| Largest segment | Detection of latent infection (skin test & igra) |
| Fastest growing segment | Detection of Drug Resistance (DST) |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Nucleic Acid Testing, Detection of Latent Infection (Skin Test & IGRA), Detection of Drug Resistance (DST), Other Methods, Phage Assay, Cytokine Detection Assay, Diagnostic Laboratory Methods, Radiographic Method |
| Key market players worldwide | Abbott Laboratories, Becton Dickinson & Co, Roche Holding AG ADR, Thermo Fisher Scientific Inc, BioMerieux SA, Qiagen NV, Hologic Inc, BD, Hain Lifescience, Cepheid |
Other key industry trends
- In terms of revenue, U.S. accounted for 25.8% of the global tuberculosis diagnostics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. tuberculosis diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- Mexico is the fastest growing regional market in North America and is projected to reach USD 17.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Tuberculosis Diagnostics Market Scope
Tuberculosis Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. tuberculosis diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to tuberculosis diagnostics market will help companies and investors design strategic landscapes.
Detection of latent infection (skin test & igra) was the largest segment with a revenue share of 41.27% in 2023. Horizon Databook has segmented the U.S. tuberculosis diagnostics market based on nucleic acid testing, detection of latent infection (skin test & igra), detection of drug resistance (dst), other methods, phage assay, cytokine detection assay, diagnostic laboratory methods, radiographic method covering the revenue growth of each sub-segment from 2018 to 2030.
The dynamics of the TB diagnostics market in the U.S. is governed by rapid technological advancements, research & development, and available funding. There has been about 5% decline in incidence of TB from 1953 to 1984. Numerous actions plans for TB control have been undertaken in the country, one of them is to strengthen laboratory testing.
Reasons to subscribe to U.S. tuberculosis diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. tuberculosis diagnostics market databook
-
Our clientele includes a mix of tuberculosis diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. tuberculosis diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into U.S. tuberculosis diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. tuberculosis diagnostics market size, by test type, 2018-2030 (US$M)
U.S. Tuberculosis Diagnostics Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
